Medial Temporal Lobe Atrophy and APOE Genotype Do Not Predict Cognitive Improvement upon Treatment with Rivastigmine in Alzheimer’s Disease Patients

Publisher： Karger

E-ISSN： 1421-9824|19|2-3|126-133

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.19, Iss.2-3, 2005-02, pp. : 126-133

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inferior Temporal Lobe Atrophy and APOE Genotypes in Alzheimer’s Disease

Dementia and Geriatric Cognitive Disorders, Vol. 9, Iss. 2, 1998-02 ,pp. : 90-98

Karger

Access to resources Recommend Favorite

Effects of Medial Temporal Atrophy and White Matter Hyperintensities on the Cognitive Functions in Patients with Alzheimer’s Disease

European Neurology, Vol. 66, Iss. 2, 2011-07 ,pp. : 75-82

Karger

Access to resources Recommend Favorite

Effect of White Matter Hyperintensity on Medial Temporal Lobe Atrophy in Alzheimer’s Disease

European Neurology, Vol. 69, Iss. 4, 2013-01 ,pp. : 229-235

Karger

Access to resources Recommend Favorite

Cerebrospinal Fluid/Serum IgG Index Is Correlated with Medial Temporal Lobe Atrophy in Alzheimer’s Disease

Dementia and Geriatric Cognitive Disorders, Vol. 25, Iss. 2, 2007-12 ,pp. : 144-147

Karger

Access to resources Recommend Favorite

APOE Genotype and Alzheimer´s Disease

Dementia and Geriatric Cognitive Disorders, Vol. 11, Iss. 4, 2000-06 ,pp. : 237-237

Karger

Access to resources Recommend Favorite